Floatz logo

Anti-Cd30-Car-Transduced T Cells

Adult T-Cell Leukemia/Lymphoma

Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyCell therapyPhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

38 Active assets in the Adult T-Cell Leukemia/Lymphoma cohort.

Asset / SponsorPhaseRating
DEXAMETHASONE
The First Affiliated Hospital of Soochow University
Phase 2BBB
Fludarabine
John Reneau
Phase 2BBB
Cyclophosphamide
John Reneau
Phase 4BBB
ETOPOSIDE
National Cancer Institute (NCI)
Phase 2BBB
cc-5013
National Cancer Institute (NCI)
Phase 2BBB

View all 50 →

Same molecule, other indications

Anti-Cd30-Car-Transduced T Cells is also rated in:

lymphomaDormant
CC
Indicative ·
46 / 100
View asset →
leukemiaDormant
CC
Indicative ·
46 / 100
View asset →
extranodal nasal NK/T cell lymphomaDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →